Erratum to: Diabetologia
DOI 10.1007/s00125-012-2534-0
In the text box ‘Properties of currently available glucose-lowering agents that may guide treatment choice in individual patients with type 2 diabetes mellitus’ vildagliptin was incorrectly assigned footnote ‘a’ (Limited use in the USA/Europe) instead of footnote ‘b’ (Not licensed in the USA).
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s00125-012-2534-0.
Rights and permissions
About this article
Cite this article
Inzucchi, S.E., Bergenstal, R.M., Buse, J.B. et al. Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 56, 680 (2013). https://doi.org/10.1007/s00125-012-2785-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-012-2785-9